Search by Drug Name or NDC
NDC 63742-0022-01 Liposomal Hemorrhoid Master 5; .25 g/100g; g/100g Details
Liposomal Hemorrhoid Master 5; .25 g/100g; g/100g
Liposomal Hemorrhoid Master is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Clinical Resolution Laboratory, Inc.. The primary component is LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE.
Product Information
| NDC | 63742-0022 |
|---|---|
| Product ID | 63742-022_0a452583-5f67-6741-e063-6294a90ab17a |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Liposomal Hemorrhoid Master |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine , Phenylephrine Hcl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 5; .25 |
| Active Ingredient Units | g/100g; g/100g |
| Substance Name | LIDOCAINE; PHENYLEPHRINE HYDROCHLORIDE |
| Labeler Name | Clinical Resolution Laboratory, Inc. |
| Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE], alpha-1 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M015 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63742-0022-01 (63742002201)
| NDC Package Code | 63742-022-01 |
|---|---|
| Billing NDC | 63742002201 |
| Package | 1 TUBE in 1 CARTON (63742-022-01) / 45 g in 1 TUBE |
| Marketing Start Date | 2024-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |